Centro de Investigaciones Cardiovasculares Dr Horacio E Cingolani, CCT-CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Centro de Investigaciones Cardiovasculares Dr Horacio E Cingolani, CCT-CONICET, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Biochem Pharmacol. 2019 Mar;161:26-36. doi: 10.1016/j.bcp.2019.01.002. Epub 2019 Jan 4.
The electrogenic sodium bicarbonate co-transporter isoform 1 (NBCe1) plays an important role in ischemia-reperfusion injury. The cardioprotective action of an antibody directed to the extracellular loop 3 (a-L3) of NBCe1 was previously demonstrated by us. However, the role of a-L3 on mitochondrial post-ischemic alterations has not yet been determined. In this study, we aimed to elucidate the effects of a-L3 on post-ischemic mitochondrial state and dynamics analysing the involved mechanisms. Isolated rat hearts were assigned to the following groups: 1) Non-ischemic control (NIC): 110 min of perfusion; 2) Ischemic control (IC): 30 min of global ischemia and 60 min of reperfusion (R); 3) a-L3: a-L3 was administered during the initial 10 min of R; 4) SB + a-L3: SB202190 (p38MAPK inhibitor) plus a-L3. Infarct size (IS) was measured by TTC staining. Developed pressure (LVDP), maximal velocities of rise and decay of LVP (+dP/dt max, -dP/dt max) and end-diastolic pressure (LVEDP) of the left ventricle were used to assess systolic and diastolic function. Mitochondrial Ca response (CaR), Ca retention capacity (CRC), membrane potential (ΔΨm) and MnSOD levels were measured. The expression of P-p38MAPK, calcineurin, P-HSP27, P-Drp1, Drp1, and OPA1 were determined. a-L3 decreased IS, improved post-ischemic recovery of myocardial function, increased P-p38MAPK, P-HSP27, P-Drp1, cytosolic Drp1, and OPA1 expression and decreased calcineurin. These effects were abolished by p38MAPK inhibition with SB. These data show that NBCe1 inhibition by a-L3 limits the cell death, improves myocardial post-ischemic contractility and mitochondrial state and dynamic through calcium decrease/calcineurin inhibition-mediated p38MAPK activation and p38MAPK/HSP27-dependent pathways. Thus, we demonstrated that a-L3 is a potential therapeutic strategy in post-ischemic alterations.
电化学钠-碳酸氢盐协同转运蛋白 1 同工型(NBCe1)在缺血再灌注损伤中发挥重要作用。我们之前已经证明了针对 NBCe1 细胞外环 3(a-L3)的抗体具有心脏保护作用。然而,a-L3 对缺血后线粒体改变的作用尚未确定。在这项研究中,我们旨在通过分析涉及的机制来阐明 a-L3 对缺血后线粒体状态和动力学的影响。分离的大鼠心脏被分配到以下组:1)非缺血对照(NIC):灌注 110 分钟;2)缺血对照(IC):30 分钟的整体缺血和 60 分钟的再灌注(R);3)a-L3:a-L3 在 R 的最初 10 分钟内给药;4)SB+a-L3:SB202190(p38MAPK 抑制剂)加 a-L3。通过 TTC 染色测量梗死面积(IS)。左心室的收缩压(LVDP)、LVP 上升和下降的最大速度(+dP/dt max、-dP/dt max)和舒张末期压力(LVEDP)用于评估收缩和舒张功能。测量线粒体 Ca 反应(CaR)、Ca 保留能力(CRC)、膜电位(ΔΨm)和 MnSOD 水平。测定 P-p38MAPK、钙调神经磷酸酶、P-HSP27、P-Drp1、Drp1 和 OPA1 的表达。a-L3 降低了 IS,改善了缺血后心肌功能的恢复,增加了 P-p38MAPK、P-HSP27、P-Drp1、胞质 Drp1 和 OPA1 的表达,并降低了钙调神经磷酸酶。这些作用被 p38MAPK 抑制剂 SB 所阻断。这些数据表明,通过 NBCe1 的 a-L3 抑制通过减少钙/钙调神经磷酸酶抑制介导的 p38MAPK 激活和 p38MAPK/HSP27 依赖性途径来限制细胞死亡,改善心肌缺血后收缩性和线粒体状态和动力学。因此,我们证明了 a-L3 是缺血后改变的潜在治疗策略。